Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol (2013) 5.33

Causes and consequences of replication stress. Nat Cell Biol (2014) 3.70

A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol (2014) 1.86

Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood (2013) 1.79

HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis. Nature (2013) 1.57

Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet (2013) 1.52

Modulation of DNA damage and repair pathways by human tumour viruses. Viruses (2015) 1.49

DNA damage response: three levels of DNA repair regulation. Cold Spring Harb Perspect Biol (2013) 1.48

The RSF1 histone-remodelling factor facilitates DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins. PLoS Biol (2014) 1.47

Noncovalent interactions with SUMO and ubiquitin orchestrate distinct functions of the SLX4 complex in genome maintenance. Mol Cell (2014) 1.45

Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry. J Biol Chem (2013) 1.43

DNA damage tolerance: a double-edged sword guarding the genome. Transl Cancer Res (2013) 1.33

Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability. Science (2016) 1.26

The genetic and biochemical basis of FANCD2 monoubiquitination. Mol Cell (2014) 1.22

Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun (2014) 1.21

Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage. Cell Cycle (2013) 1.17

Targeting DNA damage response in cancer therapy. Cancer Sci (2014) 1.16

Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage. Mol Cell (2014) 1.15

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma. Front Oncol (2012) 1.14

BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork. Mol Cell (2014) 1.14

Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood (2013) 1.13

Fancd2 is required for nuclear retention of Foxo3a in hematopoietic stem cell maintenance. J Biol Chem (2014) 1.00

Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther (2013) 0.99

The roles of DNA polymerase ζ and the Y family DNA polymerases in promoting or preventing genome instability. Mutat Res (2012) 0.99

DNA repair diseases: What do they tell us about cancer and aging? Genet Mol Biol (2014) 0.98

The BLM dissolvasome in DNA replication and repair. Cell Mol Life Sci (2013) 0.97

Transcriptional repressor ZBTB1 promotes chromatin remodeling and translesion DNA synthesis. Mol Cell (2014) 0.97

'BRCAness' and its implications for platinum action in gynecologic cancer. Anticancer Res (2014) 0.96

Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96

Abundance of the Fanconi anaemia core complex is regulated by the RuvBL1 and RuvBL2 AAA+ ATPases. Nucleic Acids Res (2014) 0.96

FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance. Biochim Biophys Acta (2014) 0.95

Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells. Cell Cycle (2014) 0.95

The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma. Mutat Res (2013) 0.95

Diseases associated with defective responses to DNA damage. Cold Spring Harb Perspect Biol (2012) 0.94

Regulation of the Rev1-pol ζ complex during bypass of a DNA interstrand cross-link. EMBO J (2015) 0.93

Readers of PCNA modifications. Chromosoma (2013) 0.93

Fanconi anemia signaling network regulates the spindle assembly checkpoint. J Clin Invest (2013) 0.92

DNA repair. Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1. Science (2014) 0.92

A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair. Nucleic Acids Res (2013) 0.92

Interplay between Fanconi anemia and homologous recombination pathways in genome integrity. EMBO J (2016) 0.92

Two-way communications between ubiquitin-like modifiers and DNA. Nat Struct Mol Biol (2014) 0.91

UHRF1 contributes to DNA damage repair as a lesion recognition factor and nuclease scaffold. Cell Rep (2015) 0.91

Mitomycin C reduces abundance of replication forks but not rates of fork progression in primary and transformed human cells. Oncoscience (2014) 0.91

FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2. PLoS Genet (2015) 0.91

PolySUMOylation by Siz2 and Mms21 triggers relocation of DNA breaks to nuclear pores through the Slx5/Slx8 STUbL. Genes Dev (2016) 0.90

DNA-damage foci to detect and characterize DNA repair alterations in children treated for pediatric malignancies. PLoS One (2014) 0.90

The auto-generated fragment of the Usp1 deubiquitylase is a physiological substrate of the N-end rule pathway. Mol Cell (2012) 0.90

Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses. EMBO J (2014) 0.90

Nuclease delivery: versatile functions of SLX4/FANCP in genome maintenance. Mol Cells (2014) 0.89

ATR-dependent phosphorylation of FANCM at serine 1045 is essential for FANCM functions. Cancer Res (2013) 0.88

Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platform. Mutagenesis (2015) 0.87

Targeting an Achilles' heel of cancer with a WRN helicase inhibitor. Cell Cycle (2013) 0.87

USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy. Mol Cancer (2013) 0.87

MCM8-9 complex promotes resection of double-strand break ends by MRE11-RAD50-NBS1 complex. Nat Commun (2015) 0.87

The Fanconi anemia ID2 complex: dueling saxes at the crossroads. Cell Cycle (2014) 0.87

Deciphering the Code of the Cancer Genome: Mechanisms of Chromosome Rearrangement. Trends Cancer (2015) 0.86

Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate. Oncotarget (2014) 0.86

RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest (2015) 0.86

Crystal structure of a Fanconi anemia-associated nuclease homolog bound to 5' flap DNA: basis of interstrand cross-link repair by FAN1. Genes Dev (2014) 0.86

EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity. Cancer Res (2013) 0.85

Helq acts in parallel to Fancc to suppress replication-associated genome instability. Nucleic Acids Res (2013) 0.85

The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway. J Biol Chem (2014) 0.84

Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance. Curr Drug Targets (2016) 0.84

Fanconi anemia: a signal transduction and DNA repair pathway. Yale J Biol Med (2013) 0.84

CRISPR-Cas9-based target validation for p53-reactivating model compounds. Nat Chem Biol (2015) 0.84

Hypersensitivity of primordial germ cells to compromised replication-associated DNA repair involves ATM-p53-p21 signaling. PLoS Genet (2014) 0.84

Oral human papillomavirus is common in individuals with Fanconi anemia. Cancer Epidemiol Biomarkers Prev (2015) 0.83

Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure. BMC Cancer (2014) 0.83

A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage. Oncogene (2015) 0.83

Fanconi anemia patients are more susceptible to infection with tumor virus SV40. PLoS One (2013) 0.83

Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model. Pediatr Blood Cancer (2013) 0.82

Drosophila FANCM helicase prevents spontaneous mitotic crossovers generated by the MUS81 and SLX1 nucleases. Genetics (2014) 0.82

The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention. Cell Biochem Biophys (2013) 0.82

Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon? Oncoscience (2014) 0.82

Functions and regulation of the multitasking FANCM family of DNA motor proteins. Genes Dev (2015) 0.82

Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood (2016) 0.82

FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair. Cell Rep (2016) 0.82

Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice. Stem Cell Res (2013) 0.81

Multiple interactions of the intrinsically disordered region between the helicase and nuclease domains of the archaeal Hef protein. J Biol Chem (2014) 0.81

The MHF complex senses branched DNA by binding a pair of crossover DNA duplexes. Nat Commun (2014) 0.81

Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma. BMC Cancer (2015) 0.81

Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair research. DNA Repair (Amst) (2014) 0.81

Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication. Chromosoma (2016) 0.81

FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene. Clin Cancer Res (2014) 0.81

Non-erythroid alpha spectrin prevents telomere dysfunction after DNA interstrand cross-link damage. Nucleic Acids Res (2013) 0.80

The SNM1B/APOLLO DNA nuclease functions in resolution of replication stress and maintenance of common fragile site stability. Hum Mol Genet (2013) 0.80

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy. Mol Cells (2015) 0.80

A protein prioritization approach tailored for the FA/BRCA pathway. PLoS One (2013) 0.80

BRCA1 Is Required for Maintenance of Phospho-Chk1 and G2/M Arrest during DNA Cross-Link Repair in DT40 Cells. Mol Cell Biol (2015) 0.80

Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes. Am J Pathol (2013) 0.80

An RNF168 fragment defective for focal accumulation at DNA damage is proficient for inhibition of homologous recombination in BRCA1 deficient cells. Nucleic Acids Res (2014) 0.80

Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma. Oncotarget (2014) 0.80

FANCD2 and REV1 cooperate in the protection of nascent DNA strands in response to replication stress. Nucleic Acids Res (2015) 0.80

The histone-fold complex MHF is remodeled by FANCM to recognize branched DNA and protect genome stability. Cell Res (2014) 0.80

Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup. Biomark Res (2015) 0.79

Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins. Mol Cancer Res (2014) 0.79

Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells. Elife (2016) 0.79

Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling. Stem Cell Reports (2014) 0.79

What is wrong with Fanconi anemia cells? Cell Cycle (2014) 0.79

FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents. Oncotarget (2014) 0.79

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (2007) 20.11

RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature (2002) 14.63

The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature (1999) 10.87

PCNA, the maestro of the replication fork. Cell (2007) 10.43

Biallelic inactivation of BRCA2 in Fanconi anemia. Science (2002) 9.31

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell (2001) 8.99

53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell (2010) 8.70

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell (2006) 7.33

Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet (2007) 7.29

Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. Science (1999) 7.20

BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell (2001) 6.75

Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell (2004) 6.12

RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol (2008) 5.90

Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science (2005) 5.75

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol (2010) 5.59

Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell (2009) 5.41

Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases. Cell (2009) 5.05

Deoxycytidyl transferase activity of yeast REV1 protein. Nature (1996) 4.96

How the fanconi anemia pathway guards the genome. Annu Rev Genet (2009) 4.94

SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature (2005) 4.88

The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science (2009) 4.85

Requirement for three novel protein complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae. Genetics (2001) 4.73

The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol (2010) 4.72

Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol (2006) 4.67

Ubiquitin-binding domains - from structures to functions. Nat Rev Mol Cell Biol (2009) 4.62

Mechanism of replication-coupled DNA interstrand crosslink repair. Cell (2008) 4.53

The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell (2005) 4.40

Regulation of homologous recombination in eukaryotes. Annu Rev Genet (2010) 4.33

DNA interstrand crosslink repair and cancer. Nat Rev Cancer (2011) 4.29

Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell (2007) 4.28

Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A (2004) 4.19

RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev (2007) 4.16

Principles of ubiquitin and SUMO modifications in DNA repair. Nature (2009) 4.10

The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet (2001) 4.07

The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol (2004) 3.94

Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci U S A (2005) 3.93

The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev (2005) 3.90

RTEL1 maintains genomic stability by suppressing homologous recombination. Cell (2008) 3.84

Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature (2011) 3.79

SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet (2011) 3.74

Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev (2009) 3.62

Mutations of the SLX4 gene in Fanconi anemia. Nat Genet (2011) 3.60

Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem (2006) 3.59

Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res (2008) 3.58

Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol (2000) 3.57

Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57

A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cell (2010) 3.51

BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell (2005) 3.44

The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell (2004) 3.44

Y-family DNA polymerases and their role in tolerance of cellular DNA damage. Nat Rev Mol Cell Biol (2012) 3.43

Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell (2010) 3.43

Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell (2009) 3.38

Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell (2010) 3.37

Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev (2010) 3.33

Structural and functional relationships of the XPF/MUS81 family of proteins. Annu Rev Biochem (2008) 3.32

Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair (Amst) (2007) 3.27

A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell (2007) 3.27

Trading places: how do DNA polymerases switch during translesion DNA synthesis? Mol Cell (2005) 3.25

FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat Struct Mol Biol (2008) 3.22

PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol (2009) 3.15

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem (2000) 3.01

Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol Cell (2010) 2.91

The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J (2006) 2.89

Novel pro- and anti-recombination activities of the Bloom's syndrome helicase. Genes Dev (2007) 2.82

FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science (2010) 2.80

Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med (2010) 2.79

Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia. Nat Genet (2011) 2.72

Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J (2003) 2.69

Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science (2010) 2.67

RAD18 transmits DNA damage signalling to elicit homologous recombination repair. Nat Cell Biol (2009) 2.67

Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol Cell (2011) 2.61

Fidelity and processivity of Saccharomyces cerevisiae DNA polymerase eta. J Biol Chem (1999) 2.54

Slx1-Slx4 is a second structure-specific endonuclease functionally redundant with Sgs1-Top3. Genes Dev (2003) 2.53

Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell (2008) 2.45

Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J (2003) 2.42

A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency. Mol Cell (2009) 2.41

MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Mol Cell (2010) 2.40

Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat Struct Mol Biol (2010) 2.40

A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol Cell (2010) 2.36

Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet (2005) 2.32

PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40. Mol Cell (2008) 2.29

Controlling the subcellular localization of DNA polymerases iota and eta via interactions with ubiquitin. EMBO J (2006) 2.25

BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell (2012) 2.21

Cellular roles of DNA polymerase zeta and Rev1 protein. DNA Repair (Amst) (2002) 2.20

Drosophila MUS312 and the vertebrate ortholog BTBD12 interact with DNA structure-specific endonucleases in DNA repair and recombination. Mol Cell (2009) 2.18

UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J Biol Chem (2008) 2.17

Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a. Mol Cell (2008) 2.16

Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res (2007) 2.14

FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol Cell (2008) 2.14

Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell (2009) 2.12

Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J (2003) 2.12

Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol Cell (2007) 2.11

Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06

Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen. Proc Natl Acad Sci U S A (2006) 2.06

Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science (2011) 2.04

DNA damage tolerance: when it's OK to make mistakes. Nat Chem Biol (2009) 2.04

Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage. Mol Cell Biol (2006) 2.02

Ubiquitin-binding domains and their role in the DNA damage response. DNA Repair (Amst) (2009) 2.02

Slx1-Slx4 are subunits of a structure-specific endonuclease that maintains ribosomal DNA in fission yeast. Mol Biol Cell (2003) 1.96

Formaldehyde catabolism is essential in cells deficient for the Fanconi anemia DNA-repair pathway. Nat Struct Mol Biol (2011) 1.95

Biallelic inactivation of BRCA2 in Fanconi anemia. Science (2002) 9.31

Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell (2007) 6.68

How the fanconi anemia pathway guards the genome. Annu Rev Genet (2009) 4.94

Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol (2006) 4.67

The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell (2005) 4.40

S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood (2002) 4.27

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med (2003) 4.04

Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci U S A (2005) 3.93

The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev (2005) 3.90

Molecular pathogenesis of Fanconi anemia: recent progress. Blood (2006) 3.76

Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell (2002) 3.71

ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev (2004) 3.44

Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev (2010) 3.33

A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol Cell (2007) 3.27

Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol (2004) 3.20

Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood (2008) 2.83

Regulation of DNA repair by ubiquitylation. Nat Rev Mol Cell Biol (2006) 2.73

Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol Cell (2011) 2.61

UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell (2006) 2.51

DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol (2006) 2.49

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Nat Med (2011) 2.35

Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell (2012) 2.26

The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet (2005) 2.23

Chromatin remodeling at DNA double-strand breaks. Cell (2013) 2.18

UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J Biol Chem (2008) 2.17

Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev Cell (2009) 2.12

Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood (2004) 2.08

A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. J Natl Cancer Inst (2012) 2.07

Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol (2002) 1.96

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol Cancer Ther (2006) 1.88

Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J Clin Invest (2007) 1.80

Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest (2012) 1.79

Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res (2003) 1.78

Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol Cell Biol (2007) 1.77

The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair (Amst) (2008) 1.74

Regulation of Rev1 by the Fanconi anemia core complex. Nat Struct Mol Biol (2012) 1.72

Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol Cell Biol (2006) 1.65

A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood (2002) 1.54

Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood (2003) 1.49

DNA polymerase POLN participates in cross-link repair and homologous recombination. Mol Cell Biol (2009) 1.47

Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1. J Biol Chem (2010) 1.43

Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver. N Engl J Med (2006) 1.42

Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev Cell (2003) 1.38

Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Invest (2010) 1.38

The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response. Mol Cell (2010) 1.35

Direct DNA binding activity of the Fanconi anemia D2 protein. J Biol Chem (2005) 1.33

DNA damage responses and their many interactions with the replication fork. Carcinogenesis (2006) 1.32

The USP1/UAF1 complex promotes double-strand break repair through homologous recombination. Mol Cell Biol (2011) 1.31

Regulation of the Fanconi anemia pathway by a SUMO-like delivery network. Genes Dev (2011) 1.28

Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage. Mol Cell (2009) 1.27

Dedicated to the core: understanding the Fanconi anemia complex. DNA Repair (Amst) (2006) 1.27

Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. Genes Dev (2009) 1.25

The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood (2002) 1.24

The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. Exp Cell Res (2006) 1.24

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Cancer Res (2003) 1.23

Synthetic lethality between CCNE1 amplification and loss of BRCA1. Proc Natl Acad Sci U S A (2013) 1.22

WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme complex. J Biol Chem (2010) 1.20

Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways. Mol Cell (2008) 1.19

Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood (2004) 1.18

The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly. J Biol Chem (2006) 1.17

Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Hum Mol Genet (2002) 1.13

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proc Natl Acad Sci U S A (2013) 1.11

FANCD2 activates transcription of TAp63 and suppresses tumorigenesis. Mol Cell (2013) 1.11

Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents. Mol Cancer Res (2012) 1.08

Regulation of the Fanconi anemia pathway by monoubiquitination. Semin Cancer Biol (2003) 1.08

Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ. J Biol Chem (2012) 1.07

RAD18-dependent recruitment of SNM1A to DNA repair complexes by a ubiquitin-binding zinc finger. J Biol Chem (2010) 1.05

Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. Mol Cancer (2012) 1.04

Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther (2013) 0.99

The interplay of Fanconi anemia proteins in the DNA damage response. DNA Repair (Amst) (2004) 0.98

Inactivation of Uaf1 causes defective homologous recombination and early embryonic lethality in mice. Mol Cell Biol (2013) 0.98

A new nuclease member of the FAN club. Nat Struct Mol Biol (2010) 0.98

Structural determinants of human FANCF protein that function in the assembly of a DNA damage signaling complex. J Biol Chem (2006) 0.97

XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res (2011) 0.93

DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res (2010) 0.90

Activation of Hif1α by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity. PLoS One (2011) 0.90

Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One (2013) 0.88

Human MutS and FANCM complexes function as redundant DNA damage sensors in the Fanconi Anemia pathway. DNA Repair (Amst) (2011) 0.88

Impaired DNA double strand break repair in cells from Nijmegen breakage syndrome patients. DNA Repair (Amst) (2005) 0.88

To the rescue: the Fanconi anemia genome stability pathway salvages replication forks. Cancer Cell (2012) 0.87

Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer. J Invest Dermatol (2011) 0.87

Biallelic inactivation of REV7 is associated with Fanconi anemia. J Clin Invest (2016) 0.86

FANCD2 hurdles the DNA interstrand crosslink. Cell (2009) 0.86

RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway. J Clin Invest (2015) 0.86

The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway. J Biol Chem (2014) 0.84

PARI overexpression promotes genomic instability and pancreatic tumorigenesis. Cancer Res (2013) 0.82

USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1. Cancer Biol Ther (2015) 0.81

Subtyping of Fanconi anemia patients: implications for clinical management. Blood (2003) 0.81

DNA damage discrimination at stalled replication forks by the Rad5 homologs HLTF and SHPRH. Mol Cell (2011) 0.78

FANCM: A landing pad for the Fanconi Anemia and Bloom's Syndrome complexes. Mol Cell (2009) 0.78

Stressed out: endogenous aldehydes damage hematopoietic stem cells. Cell Stem Cell (2012) 0.77

HAUSP hunting the FOX(O). Nat Cell Biol (2006) 0.76

Biallelic inactivation of REV7 is associated with Fanconi anemia. J Clin Invest (2017) 0.75